Apyx Medical Corporation (APYX)
USD 1.16
(-5.69%)
USD 1.16
(-5.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.12 Million USD | -51.52% |
| 2022 | 29.13 Million USD | -13.3% |
| 2021 | 33.6 Million USD | 91.96% |
| 2020 | 17.5 Million USD | -8.49% |
| 2019 | 19.12 Million USD | 77.22% |
| 2018 | 10.79 Million USD | -45.38% |
| 2017 | 19.76 Million USD | 10.3% |
| 2016 | 17.91 Million USD | 42.67% |
| 2015 | 12.55 Million USD | 39.65% |
| 2014 | 8.99 Million USD | -2.24% |
| 2013 | 9.19 Million USD | -18.84% |
| 2012 | 11.33 Million USD | 5.61% |
| 2011 | 10.73 Million USD | 7.44% |
| 2010 | 9.98 Million USD | -15.75% |
| 2009 | 11.85 Million USD | 0.05% |
| 2008 | 11.84 Million USD | 4.71% |
| 2007 | 11.31 Million USD | 6.74% |
| 2006 | 10.6 Million USD | 40.19% |
| 2005 | 7.56 Million USD | -5.25% |
| 2004 | 7.98 Million USD | 12.15% |
| 2003 | 7.11 Million USD | 35.39% |
| 2002 | 5.25 Million USD | -8.74% |
| 2001 | 5.75 Million USD | 7.86% |
| 2000 | 5.33 Million USD | 6.61% |
| 1999 | 5 Million USD | 58.12% |
| 1998 | 3.16 Million USD | -2.0% |
| 1997 | 3.23 Million USD | -3.55% |
| 1996 | 3.35 Million USD | 45.36% |
| 1995 | 2.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.81 Million USD | -52.75% |
| 2024 Q1 | 5.94 Million USD | 46.45% |
| 2023 FY | 14.12 Million USD | -51.52% |
| 2023 Q1 | 7.57 Million USD | -8.11% |
| 2023 Q4 | 4.06 Million USD | -49.08% |
| 2023 Q3 | 7.97 Million USD | -14.02% |
| 2023 Q2 | 9.27 Million USD | 22.53% |
| 2022 Q3 | 5.75 Million USD | -16.73% |
| 2022 FY | 29.13 Million USD | -13.3% |
| 2022 Q4 | 8.24 Million USD | 43.15% |
| 2022 Q2 | 6.91 Million USD | -15.88% |
| 2022 Q1 | 8.21 Million USD | -32.36% |
| 2021 Q4 | 12.15 Million USD | 50.83% |
| 2021 FY | 33.6 Million USD | 91.96% |
| 2021 Q1 | 5.86 Million USD | -23.91% |
| 2021 Q2 | 7.53 Million USD | 28.57% |
| 2021 Q3 | 8.05 Million USD | 6.93% |
| 2020 FY | 17.5 Million USD | -8.49% |
| 2020 Q3 | 4.72 Million USD | 125.64% |
| 2020 Q2 | 2.09 Million USD | -29.83% |
| 2020 Q1 | 2.98 Million USD | -46.36% |
| 2020 Q4 | 7.7 Million USD | 62.98% |
| 2019 Q1 | 3.72 Million USD | 5.59% |
| 2019 FY | 19.12 Million USD | 77.22% |
| 2019 Q4 | 5.56 Million USD | 10.88% |
| 2019 Q3 | 5.01 Million USD | 12.19% |
| 2019 Q2 | 4.47 Million USD | 20.22% |
| 2018 Q1 | 4.99 Million USD | -15.41% |
| 2018 Q3 | 2.52 Million USD | -59.84% |
| 2018 Q4 | 3.52 Million USD | 39.75% |
| 2018 FY | 10.79 Million USD | -45.38% |
| 2018 Q2 | 6.27 Million USD | 25.79% |
| 2017 Q3 | 4.59 Million USD | -8.89% |
| 2017 FY | 19.76 Million USD | 10.3% |
| 2017 Q2 | 5.04 Million USD | 19.31% |
| 2017 Q1 | 4.22 Million USD | -12.51% |
| 2017 Q4 | 5.89 Million USD | 28.41% |
| 2016 Q4 | 4.83 Million USD | -4.58% |
| 2016 Q3 | 5.06 Million USD | 7.7% |
| 2016 Q2 | 4.7 Million USD | 41.44% |
| 2016 Q1 | 3.32 Million USD | -5.44% |
| 2016 FY | 17.91 Million USD | 42.67% |
| 2015 FY | 12.55 Million USD | 39.65% |
| 2015 Q4 | 3.51 Million USD | 8.83% |
| 2015 Q3 | 3.22 Million USD | 2.83% |
| 2015 Q2 | 3.14 Million USD | 17.43% |
| 2015 Q1 | 2.67 Million USD | 9.55% |
| 2014 Q2 | 1.87 Million USD | -31.89% |
| 2014 Q1 | 2.75 Million USD | 7.32% |
| 2014 Q3 | 1.91 Million USD | 2.24% |
| 2014 FY | 8.99 Million USD | -2.24% |
| 2014 Q4 | 2.44 Million USD | 27.2% |
| 2013 Q3 | 2.24 Million USD | 0.85% |
| 2013 FY | 9.19 Million USD | -18.84% |
| 2013 Q4 | 2.56 Million USD | 14.18% |
| 2013 Q2 | 2.23 Million USD | 3.67% |
| 2013 Q1 | 2.15 Million USD | -22.82% |
| 2012 Q2 | 2.85 Million USD | 2.15% |
| 2012 Q3 | 2.89 Million USD | 1.33% |
| 2012 FY | 11.33 Million USD | 5.61% |
| 2012 Q4 | 2.78 Million USD | -3.7% |
| 2012 Q1 | 2.79 Million USD | 5.67% |
| 2011 Q4 | 2.64 Million USD | 1.53% |
| 2011 Q3 | 2.6 Million USD | -14.42% |
| 2011 Q1 | 2.43 Million USD | -9.32% |
| 2011 Q2 | 3.04 Million USD | 25.15% |
| 2011 FY | 10.73 Million USD | 7.44% |
| 2010 FY | 9.98 Million USD | -15.75% |
| 2010 Q3 | 2.7 Million USD | 16.72% |
| 2010 Q4 | 2.68 Million USD | -0.76% |
| 2010 Q2 | 2.31 Million USD | 1.38% |
| 2010 Q1 | 2.28 Million USD | -18.22% |
| 2009 Q1 | 3.31 Million USD | 6.1% |
| 2009 Q4 | 2.79 Million USD | 1.23% |
| 2009 Q3 | 2.75 Million USD | -7.42% |
| 2009 Q2 | 2.98 Million USD | -10.2% |
| 2009 FY | 11.85 Million USD | 0.05% |
| 2008 Q4 | 3.12 Million USD | -3.23% |
| 2008 Q2 | 2.9 Million USD | 12.16% |
| 2008 Q1 | 2.58 Million USD | -2.65% |
| 2008 FY | 11.84 Million USD | 4.71% |
| 2008 Q3 | 3.23 Million USD | 11.48% |
| 2007 Q1 | 2.48 Million USD | -4.24% |
| 2007 Q2 | 3.03 Million USD | 22.36% |
| 2007 Q4 | 2.65 Million USD | -14.75% |
| 2007 Q3 | 3.11 Million USD | 2.57% |
| 2007 FY | 11.31 Million USD | 6.74% |
| 2006 Q2 | 2.89 Million USD | 25.41% |
| 2006 Q3 | 2.88 Million USD | -0.4% |
| 2006 Q4 | 2.59 Million USD | -10.0% |
| 2006 FY | 10.6 Million USD | 40.19% |
| 2006 Q1 | 2.3 Million USD | 4.53% |
| 2005 FY | 7.56 Million USD | -5.25% |
| 2005 Q3 | 2.11 Million USD | 32.96% |
| 2005 Q4 | 2.2 Million USD | 4.33% |
| 2005 Q1 | 1.65 Million USD | -10.78% |
| 2005 Q2 | 1.59 Million USD | -3.64% |
| 2004 FY | 7.98 Million USD | 12.15% |
| 2004 Q1 | 1.84 Million USD | 3.9% |
| 2004 Q2 | 2.18 Million USD | 18.97% |
| 2004 Q3 | 2.26 Million USD | 3.68% |
| 2004 Q4 | 1.84 Million USD | -18.5% |
| 2003 FY | 7.11 Million USD | 35.39% |
| 2003 Q2 | 1.97 Million USD | 26.13% |
| 2003 Q1 | 1.56 Million USD | 36.13% |
| 2003 Q4 | 1.77 Million USD | -2.18% |
| 2003 Q3 | 1.81 Million USD | -8.16% |
| 2002 Q2 | 1.21 Million USD | -7.94% |
| 2002 FY | 5.25 Million USD | -8.74% |
| 2002 Q4 | 1.14 Million USD | -26.63% |
| 2002 Q3 | 1.56 Million USD | 28.38% |
| 2002 Q1 | 1.32 Million USD | -33.82% |
| 2001 Q2 | 1.13 Million USD | -7.16% |
| 2001 Q4 | 2 Million USD | 43.68% |
| 2001 Q3 | 1.39 Million USD | 22.2% |
| 2001 Q1 | 1.22 Million USD | -33.04% |
| 2001 FY | 5.75 Million USD | 7.86% |
| 2000 Q1 | 1.1 Million USD | 0.0% |
| 2000 Q2 | 1.17 Million USD | 5.5% |
| 2000 Q3 | 1.22 Million USD | 4.95% |
| 2000 FY | 5.33 Million USD | 6.61% |
| 2000 Q4 | 1.83 Million USD | 49.28% |
| 1999 FY | 5 Million USD | 58.12% |
| 1998 FY | 3.16 Million USD | -2.0% |
| 1997 FY | 3.23 Million USD | -3.55% |
| 1996 FY | 3.35 Million USD | 45.36% |
| 1995 FY | 2.3 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 550.175% |
| Cerus Corporation | 86.4 Million USD | 83.655% |
| OrthoPediatrics Corp. | 111.25 Million USD | 87.306% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -1809.602% |
| Talis Biomedical Corporation | 371 Thousand USD | -3706.469% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -70.741% |
| Inogen, Inc. | 126.69 Million USD | 88.854% |
| Spectral AI, Inc. | 7.88 Million USD | -79.213% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 314.229% |
| CVRx, Inc. | 33.03 Million USD | 57.257% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -23050.82% |
| Orthofix Medical Inc. | 486.27 Million USD | 97.096% |
| Venus Concept Inc. | 52.16 Million USD | 72.929% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -453.804% |
| Bioventus Inc. | 328.19 Million USD | 95.697% |
| BrainsWay Ltd. | 23.09 Million USD | 38.842% |
| Envoy Medical, Inc. | -473 Thousand USD | 3085.624% |
| electroCore, Inc. | 13.22 Million USD | -6.775% |
| IceCure Medical Ltd | 1.3 Million USD | -986.308% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 333.421% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 29933.531% |
| MaxCyte, Inc. | 36.54 Million USD | 61.358% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -2993.423% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -16502.398% |
| PAVmed Inc | -3.96 Million USD | 455.897% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 357.466% |
| RxSight, Inc. | 53.76 Million USD | 73.734% |
| Sight Sciences, Inc. | 69.17 Million USD | 79.585% |
| SI-BONE, Inc. | 109.42 Million USD | 87.094% |
| TELA Bio, Inc. | 40.11 Million USD | 64.794% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 11.216% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 90.705% |
| LivaNova PLC | 771.25 Million USD | 98.169% |
| 908 Devices Inc. | 25.32 Million USD | 44.23% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 95.447% |
| Nemaura Medical Inc. | -1.47 Million USD | 1056.521% |
| NeuroPace, Inc. | 48.12 Million USD | 70.654% |
| LENSAR, Inc. | 21.1 Million USD | 33.093% |
| Cutera, Inc. | 41.49 Million USD | 65.966% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 23.504% |
| BioSig Technologies, Inc. | 18 Thousand USD | -78355.556% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 86.301% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -3.731% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 98.41% |
| Axonics, Inc. | 274.55 Million USD | 94.856% |
| Outset Medical, Inc. | 29 Million USD | 51.303% |
| IRIDEX Corporation | 21.8 Million USD | 35.241% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 80.124% |
| IRadimed Corporation | 50.15 Million USD | 71.845% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -4820.557% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1200.203% |
| Telesis Bio, Inc. | 16.95 Million USD | 16.684% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 87.479% |
| Varex Imaging Corporation | 256.9 Million USD | 94.503% |
| Quipt Home Medical Corp. | 163.84 Million USD | 91.381% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3578.325% |
| Pulmonx Corporation | 50.75 Million USD | 72.174% |
| Dynatronics Corporation | 7.63 Million USD | -84.965% |
| Modular Medical, Inc. | -768 Thousand USD | 1938.802% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -154.542% |
| Semler Scientific, Inc. | 61.2 Million USD | 76.925% |
| InMode Ltd. | 411.34 Million USD | 96.567% |
| Bruker Corporation | 1.51 Billion USD | 99.069% |
| Cytosorbents Corporation | 22.39 Million USD | 36.933% |
| DexCom, Inc. | 2.28 Billion USD | 99.383% |
| Align Technology, Inc. | 2.71 Billion USD | 99.481% |
| Viveve Medical, Inc. | 620 Thousand USD | -2177.742% |
| ZimVie Inc. | 290.38 Million USD | 95.137% |
| Movano Inc. | -158 Thousand USD | 9037.975% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 87.094% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -16502.398% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 96.159% |
| Profound Medical Corp. | 4.51 Million USD | -212.847% |
| Insulet Corporation | 1.15 Billion USD | 98.782% |
| enVVeno Medical Corporation | -546 Thousand USD | 2686.447% |
| Surmodics, Inc. | 93.05 Million USD | 84.824% |
| iCAD, Inc. | 14.53 Million USD | 2.848% |
| Nuwellis, Inc. | 4.98 Million USD | -183.404% |
| Biotricity, Inc. | 8.35 Million USD | -68.999% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 95.744% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 4033.08% |
| InspireMD, Inc. | 1.8 Million USD | -681.516% |
| PAVmed Inc. | -3.96 Million USD | 455.897% |
| BIOLASE, Inc. | 16.72 Million USD | 15.558% |
| Beyond Air, Inc. | -1.3 Million USD | 1180.49% |
| FONAR Corporation | 45.14 Million USD | 68.715% |
| AxoGen, Inc. | 127.87 Million USD | 88.956% |
| Vivani Medical, Inc. | -357 Thousand USD | 4055.742% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 92.763% |
| Inari Medical, Inc. | 434.56 Million USD | 96.75% |
| UFP Technologies, Inc. | 112.22 Million USD | 87.416% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -112704.537% |
| Tenon Medical, Inc. | 1.24 Million USD | -1037.953% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 17534.568% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -437.553% |
| AdaptHealth Corp. | 479.56 Million USD | 97.055% |
| Sintx Technologies, Inc. | 1.84 Million USD | -666.251% |
| NanoVibronix, Inc. | 1.53 Million USD | -818.803% |
| Quanterix Corporation | 70.64 Million USD | 80.01% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3578.325% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -0.441% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 73.244% |
| TransMedics Group, Inc. | 154.09 Million USD | 90.835% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -217.135% |
| NeuroMetrix, Inc. | 3.94 Million USD | -257.753% |
| Hyperfine, Inc. | 4.75 Million USD | -196.868% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 86.799% |
| Biomerica, Inc. | 611 Thousand USD | -2211.293% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 66.124% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1908.299% |
| Silk Road Medical, Inc | 127.08 Million USD | 88.888% |